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SUMMARY – When working with dermatology patients, the question sometimes arises which 
diagnostic tests and tools should be used for workup, particularly in cases of chronic urticaria (CU) 
and discoid nummular eczema, where the treatment of associated systemic diseases and infections may 
be crucial for patient outcome. The aim was to investigate retrospectively the influence of associated 
diseases on skin disease outcomes based on medical records of CU and nummular eczema patients in 
comparison to controls. We included patients admitted to our Dermatology Department over a 6-year 
period and analyzed their laboratory findings, related factors and outcomes recorded after two years of 
workup and treatment. Compared to controls, CU patients had a significantly higher prevalence of 
positive Helicobacter (H.) pylori findings (p=0.020), confirmed allergies (p=0.006), increased IgE 
(p=0.011) and pathologic thyroid findings (p=0.049), whereas nummular eczema patients only had 
significantly higher positive H. pylori findings (p=0.046). Meaningful regression of both dermatoses 
was recorded after treatment of associated diseases, with significant benefit from H. pylori treatment. 
This indicated that the diagnosis of associated infections (particularly H. pylori and urogenital infec-
tions), confirmed allergies, endocrine disorders (particularly of thyroid gland in CU patients) and se-
rum malignancy markers could play a crucial role, as their treatment may improve disease outcomes.
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Introduction
When working with dermatology patients, the 
question sometimes arises which diagnostic tests and 
tools should be used for workup. With some skin dis-
eases, particularly in cases of discoid nummular ecze-
ma and chronic urticaria (CU), there is evidence for 
associated systemic diseases or disorders and infec-
tions, so some dermatologists will check for such con-
ditions even as others oppose this approach. Although 
the literature does mention a possible connection with 
particular associated diseases, there are no clear recom-
mendations on whether they should be tested for at all 
and, if so, when. In addition, as no sufficient clinical 
evidence for the influence of diagnostics and treatment 
of associated conditions has been provided, it remains 
an open question concerning patients with CU and 
nummular eczema. 
Typical of CU is the recurrence of hives within a 
period of six weeks or longer, accompanied by angio-
edema in about 50% of cases1. Recently, the term 
spontaneous CU has been in use, particularly in Eu-
rope, more than the term chronic idiopathic CU, used 
in the U. S. CU occurs in 1% of the population; its 
frequency is higher in adults, particularly in women 
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and people aged 30 to 502,3. The usual associated dis-
eases are autoimmune diseases and various infections. 
Evidence for associated malignant disorders is still in-
conclusive4,5. Diagnosis is based on clinical manifesta-
tions along with laboratory and diagnostic tests, e.g., 
autologous serum skin test (ASST). 
Nummular eczema (synonyms: nummular or dis-
coid dermatitis), discovered by Marie Guillaume Al-
phonse Devergie in the 19th century, is characterized 
by discoid skin lesions commonly on the extremities 
(particularly legs), but also elsewhere (trunk, hands, 
face, and neck)6,7. Clinically recognizable manifesta-
tions are pruritic skin with coin-shaped erythematous 
patches, with papules and vesicles in the acute phase 
and crusts and desquamation in the chronic phase7. 
Men usually get nummular eczema late in life, whereas 
women get it at a younger age7. The etiologic cause of 
the disease is unclear but is considered to be multifac-
torial with many possible triggers and related factors 
such as atopic dermatitis (AD), dry skin, mental stress, 
weather conditions, infection and alcohol6,7. Nummu-
lar eczema often takes a chronic and recurrent course. 
As the association and influence of different factors 
and diseases possibly related to CU and nummular ec-
zema outcome have been underexplored, we decided 
to carry out this study and research them.
Subjects and Methods
Subjects
We conducted a retrospective study to investigate 
the prevalence of associated diseases recorded and 
their characteristics in patients with CU and nummu-
lar eczema on the basis of medical records and in com-
parison to control subjects. We included patients ad-
mitted to the Dermatology Department, including 
outpatients, over a 6-year period ( January 1, 2010 to 
December 31, 2015) and recorded their laboratory 
findings, related factors and outcomes recorded after 
two years of workup and treatment. Only patients with 
complete medical records containing evidence re-
quired for diagnosing a dermatosis or an associated 
disease were taken into consideration.
We included CU patients treated with H1-antihis-
tamines, while excluding those having received sys-
temic immunosuppressant therapy (cyclosporine, 
montelukast, omalizumab, and others), patients with 
chronic inducible urticaria, drug-induced urticaria/an-
gioedema, and those taking systemic corticosteroids at 
long-term. Another group included patients with 
nummular eczema treated with topical corticosteroid 
preparations and systemic antihistamines, excluding 
those with AD (diagnosed by Hanifin-Rajka criteria) 
and asteatotic dermatitis. Finally, 30 adult control sub-
jects with vulgar psoriasis were included as controls. 
All participants signed a written informed consent, 
and the study was conducted according to the Hel-
sinki Declaration guidelines.
Methods
During the above-mentioned 2-year testing and 
treatment, medical records of all patients were docu-
mented together with their outcomes after that period 
(regression or persistent disease).
Laboratory tests
The following tests were carried out in all three 
groups: complete blood count (CBC) with differential 
blood count (DBC), erythrocyte sedimentation rate 
(ESR), C-reactive protein (CRP), urine (when bacteri-
uria was found, urine cultures, cervical or urethral swabs 
were performed), glucose (GLC), creatinine, urea, AST, 
ALT, GGT, ALP, bilirubin, thyroid-stimulating hor-
mone (TSH) levels, free T3 and T4 (thyroid hormones), 
anti-thyroid peroxidase (antiTPO) and anti-thyroglob-
ulin (antiTg) antibodies, antinuclear antibodies (ANA), 
total immunoglobulin E (IgE), serum protein electro-
phoresis, rheumatoid factor (RF), LDH, cholesterol, 
LDL, triglycerides, HDL, anti-streptolysin O (ASO), 
anti-staphylosin (ASTA), nasal and throat swabs, stool 
tests for Helicobacter pylori (H. pylori), parasites and 
Candida, perianal tape test for oxyuriasis, rapid plasma 
reagin (RPR) test, and chest radiography.
Additionally, based on the patient medical history 
and self-reported symptoms and/or in consultation 
with colleagues from the related fields, some patients 
underwent the following laboratory tests: hepatitis B 
and C serology, EBV and CMV serology, Koch’s bacil-
lus, sputum culture, paranasal sinus radiography, ab-
dominal and pelvic ultrasound, intradermal injection 
of purified protein derivative of Mycobacterium tuber-
culosis (PPD) or QuantiFERON test, serum immuno-
globulins (IgG, IgA, IgM), HIV-serology test, levels of 
complement proteins C3 and C4, serum tumor marker 
analyses, and others.
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Allergy skin tests and other skin tests
We performed standard prick tests for aeroaller-
gens and foods by applying allergen solutions to the 
forearm and patch tests for contact allergens with al-
lergens applied to patient upper back (following the 
European Society of Contact Dermatitis guidelines)8,9. 
Standard allergen kits supplied by the Institute of Im-
munology, Zagreb, Croatia, were used8. A positive re-
action was recorded if the patient was positive to any 
of the tested allergens. We also performed direct im-
munofluorescent tests (DIF) to look for urticarial vas-
culitis; patients having tested positive were excluded 
from the study, and ASST to examine for potential 
autoimmune urticaria.
Outcome evidence
Patients whose laboratory tests revealed irregular 
findings were referred to their primary doctor for fur-
ther therapy. Finally, we recorded patient outcomes 
after two years of initial tests and treatment of derma-
toses and related diseases. Resolution was recorded 
when the patient was free from hives/eczema for at 
least 6 months. 
Statistical analysis
Differences between individual disease groups (CU 
and nummular eczema) and the control group were 
analyzed by Fisher exact test. Results are presented in 
tables with multiple fields. All p values below 0.05 
were considered significant. The IBM SPSS Statistics, 
version 25, was used on all statistical analyses. 
Results
The study included 160 CU patients, 110 (68.8%) 
women and 50 (31.2%) men, age range 16-83, mean 
age 46.82 years (Table 1). There were 123 nummular 
eczema patients, 78 (63.4%) women and 45 (36.6%) 
men, age range 16-95, mean age 55.57 years (Table 2). 
Control group consisted of 30 patients with vulgar 
psoriasis (15 male and 15 female, age range 26-89, 
mean age 51.2 years).
Results in CU patients
The most common pathologic deviation was H. py-
lori infection (33.8%), followed by positive skin allergy 
tests (30.0%), mostly to contact allergens (10.0%) and 
Table 2. Comparison of the most common results  








Patients, N 123 30
Female 78 (63.4%) 15 (50.0%)
Male 45 (36.6%) 15 (50.0%)
HP infection 38 (30.9%) 4 (13.33%) 0.046*
Confirmed allergy 26 (21.1%) 2 (6.67%)
Elevated IgE 17 (13.8%) 2 (6.67%)
UG infections 14 (11.4%) 6 (20.0%)
Uroinfection 10 (8.1%) 4 (13.33%)
Genital infection 9 (7.32%) 2 (6.67%)
Thyroid. disorder 4 (83.3%) 1 (3.33%)
Increased 
Candida 11 (8.9%) 2 (6.67%)
Positive ANA 15 (12.2%) 1 (3.33%)
*statistically significant result; HP = Helicobacter pylori; UG = uro-
genital; ANA = antinuclear antibodies
Table 1. Comparison of the most common results  








Patients, N 160 30
Female 110 (68.8%) 15 (50.0%)
Male 50 (31.2%) 15 (50.0%)
HP infection 54 (33.8%) 4 (13.33%) 0.020*
Confirmed 
allergy 48 (30.0%) 2 (6.67%) 0.006*
Elevated IgE 43 (26.9%) 2 (6.67%) 0.011*
UG infections 40 (25.0%) 6 (20.0%) 
Uroinfection 15 (9.38%) 4 (13.33%)
Genital infection 30 (18.75%) 2 (6.67%)
Thyroid disorder 27 (16.9%) 1 (3.33%) 0.049*
Increased 
Candida  19 (11.9%) 2 (6.67%) <0.001*
Positive ANA  13 (8.1%) 1 (3.33%) 
PositiveASST  8 (5.0%) 0 (0%)
*statistically significant results; HP = Helicobacter pylori; UG = uro-
genital; ANA = antinuclear antibodies; ASST = autologous serum 
skin test
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foods (9.38%), and by elevated IgE (26.9%). Also 
common were urogenital infections (25.0%) (Table 1). 
When bacteriuria was present (21.25%), microbiologi-
cal analysis of urine was conducted and revealed Esch-
erichia coli (E. coli) as the most common cause of uri-
nary tract infection (6.88%). Ureaplasma was the 
pathologic finding most commonly isolated in cervical 
(14.37%) and urethral (4.38%) swabs. Some patients 
had overlapping infections, both genital and urinary 
tract infection. The next most common serum labora-
tory findings were thyroid disorders (16.9%) (antiT-
PO in 12.5% and elevated TSH in 8.13%) and positive 
ANA (8.1%). Some CU patients also showed elevated 
blood lipids (7.5%) and glucose levels (3.1%). Con-
cerning microbiological findings, elevated stool Can-
dida colonization was recorded in 11.9%, whereas nose 
and throat swabs showed Staphylococcus as the most 
frequent pathologic finding (11.25%). Tumor marker 
analysis showed elevated CA15-3 in 4.38%, and ele-
vated PSA and CEA in 1.25% of CU patients. 
Results in nummular eczema patients
For this disease, the most common pathologic de-
viation was H. pylori (30.9%), followed by confirmed 
allergies (21.1%) and elevated IgE values (13.8%). On 
allergy testing, most patients were positive for cobalt 
(5.69%), weed pollen (4.88%) and mites (4.07%). The 
next most common finding was urogenital infection 
(11.4%) (Table 2). After finding bacteriuria (24.39%), 
according to urine cultures, the most frequent urinary 
tract infections were triggered by E. coli (5.69%), and 
Candida (3.25%). Looking at cervical/urethral smears, 
Ureaplasma and Streptococcus were the most frequent 
finding in women (3.25%), while only Ureaplasma was 
commonly found in men (6.5%). Other serum labora-
tory findings were less commonly positive, as follows: 
ANA (12.2%), elevated blood glucose (4.1%) and ele-
vated blood lipids (4.1%). The most frequent endocrine 
laboratory findings were thyroid disturbances, record-
ed in 3.3% (positive antiTPO in 4.88% and elevated 
TSH in 4.88%). Tumor marker analyses showed ele-
vated PSA (7.32%), CA19-9 (3.25%) and CEA 
(2.44%) in nummular eczema patients. Microbiologi-
cal analyses showed increased stool Candida in some 
patients (8.9%), and nose and throat swabs indicated 
Staphylococcus as the most frequent pathologic finding 
(14.63%). 
Summary of results in CU  
and nummular eczema patients
Statistical analysis of our data for CU and num-
mular eczema showed no significant differences in age 
and gender distribution but frequently confirmed as-
sociated infections (particularly H. pylori and urogeni-
tal infections), allergies and increased IgE, endocrine 
disorders (particularly of thyroid gland in CU patients) 
and positive malignancy markers. Thus, in CU patients 
the most significant findings were H. pylori infection 
(p=0.020) [also significant in nummular eczema pa-
tients (p=0.046)], as well as confirmed allergies (p= 
0.006) and accompanying increased IgE (p=0.011), 
and abnormal thyroid gland findings (p=0.049) (Ta-
bles 1 and 2). 
Improvement after 2-year treatment was observed 
in 117/160 (73.1%) CU patients (Fig. 1) and 76/123 
(61.8%) nummular eczema patients (Fig. 2). Disease 
remission after tests and therapy was also significantly 
more common in the CU group than in the nummular 
eczema group (73.1% vs. 61.8%) (Fig. 3).
Fig. 1. Regression of chronic urticaria after specific 
therapy of common associated conditions in these patients.
Fig. 2. Regression of nummular eczema after specific 
therapy of common associated conditions in these patients.
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In summary, in comparison to controls, CU pa-
tients had a significantly higher prevalence of positive 
H. pylori findings, significantly more confirmed aller-
gies and increased IgE findings and significant patho-
logic thyroid findings (Table 1). In comparison to con-
trols, nummular eczema patients also had a signifi-
cantly higher prevalence of positive H. pylori findings 
(p=0.046). Remarkably, while pathologic thyroid find-
ings were significantly higher in the CU group com-
pared to controls (16.9% vs. 3.2%; p=0.049), these 
findings in the nummular eczema group were nearly 
the same as in controls (3.3% vs. 3.2%; p=1.000) (Ta-
ble 2). On the other hand, the controls (psoriatic pa-
tients) had a significantly higher prevalence of elevated 
blood glucose levels (CU p=0.011 and nummular ec-
zema p=0.029) and higher cholesterol and LDL find-
ings (CU p<0.001 and nummular eczema p<0.001) 
compared to both patient groups. 
Discussion
Urticaria is one of the most common dermatologic 
and allergic diseases, with varied etiopathogenetic 
mechanisms and triggers10. In recent years, CU has 
been increasingly perceived as a systemic disorder that 
includes systemic immune processes manifesting pri-
marily on the skin, and associated with different dis-
eases/dysfunctions (autoimmune diseases, atopy, infec-
tions, metabolic conditions, neoplastic disorders, 
etc.)10-12. According to a recent Brazilian study by Dio-
nigi et al. that included chronic spontaneous urticaria 
(CSU) patients (follow-up), the main associated dis-
eases diagnosed were, in descending order by frequen-
cy, syphilis, parasites and protozoa infections (giardia-
sis, toxocariasis), H. pylori and urinary infections, tu-
berculosis and hepatitis B and C4. Our results are 
somewhat similar, but they also differed, probably due 
to geographic and cultural differences. The association 
between CU and infections can be considered more 
direct in cases where urticaria disappeared after infec-
tion treatment, as observed in urinary infections, para-
sitosis, hepatitis C and H. pylori infections4. According 
to our results, the most common related factor in CU 
patients was H. pylori, which is in accordance with 
other authors’ observations. According to literature 
data, 84% of CU patients demonstrated significant 
improvement or complete CU remission after H. py-
lori eradication, in contrast to 45% of untreated H. py-
lori positive and 29% of untreated H. pylori negative 
patients with CU11. Therefore, H. pylori infection 
screening is useful in CU patients, along with eradica-
tion when found. However, it is possible that the ben-
Fig. 3. Percentage of urticaria/eczema regression in patients with chronic urticaria  
or nummular eczema after specific treatment of their associated condition.
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eficial effects of H. pylori therapy on CU outcome in 
patients with recorded infection are predominantly 
consequences of the combination of medicines includ-
ed in therapy. 
According to our other significant results, con-
firmed allergies (positive allergy skin tests) and elevat-
ed IgE titer (atopy) were also common in CU patients. 
This connection between CU and atopic conditions 
(such as AD) suggests probable similarities in their 
immunopathogenesis and usefulness of allergy skin 
tests in CU patients13-26 . As supported by the litera-
ture4, and according to our results, urinary and genital 
infections are also common among the associated dis-
eases; however, concomitant genital infections, espe-
cially Ureaplasma (confirmed by cervical/urethral 
swabs), are often overlooked. Another common find-
ing in CU patients was irregular thyroid function. Al-
though antithyroid antibodies are generally observed 
in 30% of CU patients, their presence is not connected 
with either thyroid gland dysfunction or CU severity 
or duration13,14. Nevertheless, in several cases we ob-
served that detection and treatment of thyroid gland 
diseases/dysfunctions contributed to CU resolution, as 
confirmed by some other researchers14.
Regarding autoimmune diseases, studies report 
that CSU occurrence may be their first manifestation, 
e.g., systemic lupus erythematosus (SLE), dermato-
myositis, polymyositis, Sjögren’s syndrome, insulin-
dependent diabetes, rheumatoid arthritis and Still’s 
disease14-17. Also, according to literature data, RF and 
ANA are significantly more prevalent in CSU patients 
than in the general population, even without clinical 
symptoms of autoimmune diseases4,18. According to 
extensive research from Israel, women with CU have a 
much higher incidence of rheumatoid arthritis, 
Sjögren’s syndrome, celiac disease, type 1 diabetes mel-
litus and SLE16. Therefore, it is necessary to be aware 
that urticaria can precede symptoms of these other 
diseases by several years, as discussed in the study by 
Dionigi et al.4.
Sometimes other infectious and parasitic diseases 
such as syphilis and tuberculosis4 are observed in CU 
patients, varying by population and geographic region, 
although these infectious diseases were less common 
in our CU patients. According to earlier studies, urti-
caria disappeared in the majority of patients with para-
sitosis after specific anti-parasitic treatment (Giardia 
lamblia, Strongyloides stercoralis, Blastocystis hominis, 
Toxocara canis)1,4. Therefore, we encourage taking down 
detailed histories of infections, particularly gastroin-
testinal, respiratory and ear-nose-throat (ENT), and 
dental infections, to conduct reliable routine diagnos-
tic work that includes DBC, CRP, H. pylori examina-
tion test and serology for Streptococci, Staphylococci, 
and Yersinia11,19. Also, according to earlier literature, 
nasal Staphylococcus aureus was more common in CU 
patients (53.2%) than in healthy persons (13.3%)20, al-
though it was less frequently observed in our study. 
However, the associated diseases and infections re-
corded in CU patients are influenced by personal hab-
its and country of origin, which is probably the crucial 
reason for differences in results. Therefore, if an infec-
tion is identified, it should be properly treated, and 
eradication should be confirmed by follow-up. 
Nowadays, diagnostic procedure for CU is focused 
on the patient positive history; however, the related 
diseases may occasionally be asymptomatic and there-
fore cannot be noted in the history. Thus, expanded 
testing to determine the cause could save money that 
would otherwise be spent for long-term therapy. Lit-
erature data regarding diagnostics in CU patients sug-
gest that analysis for CRP, procalcitonin, plasma fibrin 
degradation products and d-dimer can also yield useful 
findings26-28. Although generally extensive laboratory 
tests are not recommended, they may be crucial for 
outcome in particular patients, as urticaria resolution 
was also recorded after treatment of related diseases, 
even such as hepatitis B and C and chronic myeloid 
leukemia4. Literature data also show that individuals 
initially diagnosed with CSU of unknown cause should 
be longitudinally followed-up, thereby allowing the 
diagnosis and treatment of associated diseases that de-
velop subsequently29 .
Unlike CU, nummular eczema is a relatively com-
mon dermatosis that is less frequently clinically re-
searched30-33. Although its etiopathogenesis is un-
known, it is mostly believed to be the result of a con-
tact allergic reaction to bacteria, viruses or fungi. Their 
antigens likely enter the skin hematogenously from a 
focal infection, although there is not enough evidence 
to confirm this definitely. In practice, in the absence of 
clear guidelines, the diagnosis is mostly based on the 
clinical picture and manifestations29-33. However, re-
lated diseases and infections (previously known as 
‘foci’) should also be examined, and many causative 
factors in its etiopathogenesis can still be taken into 
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account, e.g., AD, dry skin, emotional stress, seasonal 
variations, contact allergies, etc.30-32. Epidemiologically, 
according to literature data, the peak incidence of dis-
ease onset is in the third and fourth decades of life 
( Jiamton et al. report on the mean age of 42.1 years)30,31 
. By gender, studies have shown that two-thirds of af-
fected persons are women30. Clinically, nummular ec-
zema lesions predominantly appeared on the upper 
(75.8%) and lower (64.5%) limbs, followed by the 
trunk, dorsal sides of hands, and on the face and neck31. 
In diagnostic procedures suitable for nummular ec-
zema patients, histopathologic results are not very use-
ful, as they are similar to those in contact dermatitis, 
AD, or even lichen and psoriasis33, . Thus, determina-
tion of related diseases and their treatment may be 
crucial for patient outcome30-37. Among the factors 
that contributed to nummular eczema regression in 
our study, most important for regression was treatment 
of H. pylori (in 30.9%), suggesting it should be tested 
for regularly. The next most frequently found associa-
tions were allergies and atopy (increased IgE deter-
mined in 13.8%), also suggesting an association with 
atopic constitution. Thus, 14% of nummular eczema 
patients had a history of AD and half had a history of 
atopy or contact dermatitis30. Allergy tests carried out 
in our nummular eczema patients established that 
contact allergies to cobalt (5.69%) predominated, fol-
lowed by allergies to inhalant allergens (weed pollen in 
4.88% and mites in 4.07%), indicating that allergens 
may participate in disease development. Other study 
results show a significantly higher number of immedi-
ate allergic skin reactions to Candida, more frequently 
observed in elderly subjects as compared to young con-
trols, as well as delayed (contact) allergies36. This is also 
supported by other study results, i.e. contact allergies 
were observed in 32.5% of patients, commonly to 
nickel sulfate (10.2%), potassium dichromate (7.3%) 
and cobalt chloride (6.1%)30. Thus, skin patch testing is 
strongly advisable in every patient with persistent 
nummular eczema30,36,37. Similarly, patch testing found 
that elderly patients with nummular eczema retained 
delayed contact sensitivity at a level comparable to that 
of the young rather than the age-matched controls 
(48%), with common allergies to Dermatophagoides fa-
rinae (46%), house dust (35%) and Candida albicans 
(85%)36.
Urogenital infections were frequently found in 
nummular eczema patients (11.4%), mainly by E. coli 
(5.69%), and so were genital infections, mainly by Ure-
aplasma and Streptococcus. Thus, we support regular 
testing and treatment for these infections in nummu-
lar eczema patients. Positive bacteriologic findings 
(Staphylococcus, Streptococcus) in nose and throat 
swabs may also be important in some nummular ec-
zema patients as antibiotic treatment may lead to im-
provement of the skin condition. This argument favors 
the focus theory33,34. Candida may also be an occasion-
al associated factor as large numbers of Candida in 
stool were observed in 8.9% of the patients.
Other less common findings in the nummular ec-
zema group included ANA and endocrine findings, 
suggesting their rare occurrence. Results on serum tu-
mor markers revealed their increase, e.g., PSA, CA19-
9 and CEA, and may indicate malignancies, suggest-
ing a need to monitor these patients for cancer in the 
future. 
The chronic and recurrent nature of nummular ec-
zema, particularly when the cause is not eliminated, 
may influence the patient’s psychological state and af-
fect their quality of life35,38-40. For this reason, expanded 
diagnostics may be helpful, even crucial.
To our knowledge, this is the first study involving a 
significant number of nummular eczema patients who 
were analyzed for numerous factors and laboratory 
tests and whose results were compared with CU pa-
tients and controls. One of the limitations of this study 
was its retrospective design, which may have specifi-
cally affected its usefulness or accuracy. 
In conclusion, when working with CU and num-
mular eczema patients, the main goal is to achieve le-
sion resolution, meaning that inclusion of many differ-
ent diagnostic tools may be crucial. Therefore, the role 
of a skilled dermatologist and inclusion of laboratory 
tests are critical and play an essential role in the even-
tual patient outcomes, particularly determination of 
associated infections (mainly H. pylori and urogenital), 
confirmed allergies, endocrine disorders (particularly 
of thyroid gland in CU patients), and malignancy 
markers.
References
 1. Zuberbier T, Aberer W, Asero R, Abdul Latiff A H, Baker D, 
Balimer-Weber B, et al. The EAACI/GA(2) LEN/EDF/WAO 
guideline for the definition, classification, diagnosis, and man-
agement of urticaria: the 2013 revision and update. Allergy. 
2014;69(7):868-87. doi: 10.1111/all.12313.
Liborija Lugović-Mihić et al. Factors related to chronic urticaria and nummular eczema resolution
602 Acta Clin Croat, Vol. 58, No. 4, 2019
 2. Najib U, Bajwa ZH, Ostro MG, Sheikh J. A retrospective re-
view of clinical presentation, thyroid autoimmunity, laboratory 
characteristics, and therapies used in patients with chronic id-
iopathic urticaria. Ann Allergy Asthma Immunol. 2009; 
103(6):496-501. doi: 10.1016/S1081-1206(10)60266-9.
 3. Lapi F, Cassano N, Pegoraro V, Cataldo N, Heiman F, Cricelli 
I, et al. Epidemiology of chronic spontaneous urticaria: results 
from a nationwide, population-based study in Italy. Br J Der-
matol. 2016;174(5):996-1004. doi: 10.1111/bjd.14470.
 4. Dionigi PCL, Menezes MCS, Forte WCN. A prospective ten-
year follow-up of patients with chronic urticaria. Allergol Im-
munopathol (Madr). 2016;44(4):286-91. doi: 10.1016/j.aller. 
2015.10.004. 
 5. Chen YJ, Wu CY, Shen JL, Chen TT, Chang YT. Cancer risk 
in patients with chronic urticaria: a population-based cohort 
study. Arch Dermatol. 2012;148(1):103-8. doi: 10.1001/arch-
dermatol.2011.682.
 6. Iwahira Y, Nagasao T, Shimizu Y, Kuwata K, Tanaka Y. Num-
mular eczema of breast: a potential dermatologic complication 
after mastectomy and subsequent breast reconstruction. Plast 
Surg Int. 2015;209458. doi: 10.1155/2015/209458
 7. Poudel RR, Belbase B, Kafle NK. Nummular eczema. J Com-
munity Hosp Intern Med Perspect. 2015;5(3):27909 doi: 
10.3402/jchimp.v5.27909
 8. Budimir J, Mravak-Stipetić M, Bulat V, Ferček I, Japundžić I, 
Lugović-Mihić L. Allergic reactions in oral and perioral dis-
eases – what do allergy skin test results show? Oral Surg Oral 
Med Oral Pathol Oral Radiol. 2019;127(1):40-48. doi: 
10.1016/j.oooo.2018.08.001. 
 9. Japundžić I, Vodanović M, Lugović-Mihić L. An analysis of 
skin prick tests to latex and patch tests to rubber additives and 
other causative factors among dental professionals and students 
with contact dermatoses. Int Arch Allergy Immunol. 2018;5: 
1-7. doi: 10.1159/000490181.
10. Darlenski R, Kazandjieva J, Zuberbier T, Tsankov N. Chronic 
urticaria as a systemic disease. Clin Dermatol. 2014;32(3): 
420-3. doi: 10.1016/j.clindermatol.2013.11.009.
11. Wedi B, Raap U, Wieczorek D, Kaap A. Urticaria and infec-
tions. Allergy Asthma Clin Immunol. 2009;5:10. https://doi.
org/10.1186/1710-1492-5-10
12. Magen E, Mishal J. Possible benefit from treatment of Helico-
bacter pylori in antihistamine-resistant chronic urticaria. Clin 
Exp Dermatol. 2013;38(1):7-12. doi: 10.1111/j.1365-2230. 
2012.04467.x.
13. Wan KS, Wu CS. The essential role of anti-thyroid antibodies 
in chronic idiopathic urticaria. Endocr Res. 2013;38:85-8. doi: 
10.3109/07435800.2012.714432.
14. Kolkhir P, Metz M, Altrichter S, Maurer M. Comorbidity of 
chronic spontaneous urticaria and autoimmune thyroid dis-
eases: a systematic review. Allergy. 2017;72(10):1440-60. doi: 
10.1111/all.13182.
15. Konstantinou GN, Asero R, Ferrer M, Knol EF, Maurer M, 
Raap U, et al. EAACI taskforce position paper: evidence for 
autoimmune urticaria and proposal for defining diagnostic cri-
teria. Allergy. 2013;68(1):27-36. doi: 10.1111/all.12056.
16. Confino-Cohen R, Chodick G, Shalev V, Leshno M, Kimhi O, 
Goldberg A. Chronic urticaria and autoimmunity: associations 
found in a large population study. J Allergy Clin Immunol. 
2012;129:1307-13. doi: 10.1016/j.jaci.2012.01.043.
17. Cho CB, Stutes SA, Altrich ML, Ardoin SP, Phillips G, Og-
bogu PU. Autoantibodies in chronic idiopathic urticaria and 
non urticarial systemic autoimmune disorders. Ann Allergy 
Asthma Immunol. 2013;110:29-33. doi:10.1111/j.1365-2133. 
2004.06042.x
18. Stitt JM, Dreskin SC. Urticaria and autoimmunity: where are 
we now? Curr Allergy Asthma Rep. 2013;13(5):555-62. doi: 
10.1007/s11882-013-0366-8.
19. Buss YA, Garrelfs UC, Sticherling M. Chronic urticaria – 
which 300 clinical parameters are pathogenetically relevant? A 
retrospective 301 investigation of 339 patients. J Dtsch Derma-
tol Ges. 2007;5:22-9. doi:10.1111/j.1610-0387.2007.06194.x
20. Ertam I, Biyikli SE, Yazkan FA, Aytimur D, Alper S. The fre-
quency of nasal carriage in chronic urticaria patients. J Eur 
Acad Dermatol Venereol. 2007;21:777-80. doi: 10.1111/j. 
1468-3083.2006.02083.x
21. Bohme M, Lannero E, Wickman M, Nordwall SL, Wahlgren 
CF. Atopic dermatitis and concomitant disease patterns in 
children up to two years of age. Acta Derm Venereol. 2002; 
82:98-103. doi:10.1080/00015550252948112
22. Aberle N, Kljaić Bukvić B, Blekić M, Vučković M, Bardak D, et 
al. Allergic diseases and atopy among schoolchildren in eastern 
Croatia. Acta Clin Croat. 2018;57(1):82-90. doi:10.20471/
acc.2018.57.01.09.
23. Ćosićkić A, Skokić F, Selimović A, Mulić M, Suljendić S, Dedić 
N, et al. Development of respiratory allergies, asthma and allergic 
rhinits in children with atopic dermatitis. Acta Clin Croat. 
2017;56(2):308-317. doi: 10.20471/acc.2017.56.02.15.
24. Lugović L, Lipozenčić J, Jakić-Razumović J. Atopic dermatitis: 
immunophenotyping of inflammatory cells in skin lesions. Int 
J Dermatol. 2001; 40: 489-94. doi: 10.1046/j.1365-4362.2001. 
01203.x.
25. Lugović L, Lipozenčić J, Jakić-Razumović J. Prominent in-
volvement of activated Th1-subset of T-cells and increased ex-
pression of receptor for IFN-gamma on keratinocytes in atopic 
dermatitis acute skin lesions. Int Arch Allergy Immunol. 
2005;137(2):125-33. doi: 10.1159/000085468.
26. Lugović-Mihić L, Krišto M, Ferček I, Bukvić I, Duvančić T. 
Primjena omalizumaba kod kronične spontane urtikarije/an-
gioedema: preporuke, iskustva i spoznaje. Acta Med Croat. 
2018;72:495-502. 
27. Kasperska-Zajac A, Grzanka A, Machura E, Mazur B, Misi-
olek M, Czecior E, et al. Analysis of procalcitonin and CRP 
concentrations in serum of patients with chronic spontaneous 
urticaria. Inflamm Res. 2013;62:309-12. doi: 10.1007/s00011-
012-0580-1.
28. Takahagi S, Mihara S, Iwamoto K, Morioke S, Okabe T, Ka-
meyoshi Y, et al. Coagulation/fibrinolysis and inflammation 
Liborija Lugović-Mihić et al. Factors related to chronic urticaria and nummular eczema resolution
Acta Clin Croat, Vol. 58, No. 4, 2019 603
markers are associated with disease activity in patients with 
chronic urticaria. Allergy. 2010;65:649-56. doi: 10.1111/j.1398 
-9995.2009.02222.x.
29. Martínez-Blanco J, García-González V, González-García J, 
Suarez-Castanon. Nummular dermatitis: report of two cases in 
children. Arch Argent Pediatr. 2016;114(4):e241-4. doi: 
10.5546/aap.2016.e241.
30. Jiamton S, Tangjaturonrusamee C, Kulthanan K. Clinical fea-
tures and aggravating factors in nummular eczema in Thais. 
Asian Pac J Allergy Immunol. 2013;31(1):36-42.
31. Bonamonte D, Foti C, Vestita M, Ranieri LD, Angelini G. 
Nummular eczema and contact allergy: a retrospective study. 
Dermatitis. 2012;23(4):153-7. doi: 10.1097/DER.0b013e3182 
60d5a0.
32. Lugović-Mihić L, Ljubešić L, Mihić J, Vuković-Cvetković V, 
Šitum M. Psychoneuroimmunologic aspects of skin diseases. 
Acta Clin Croat. 2013;52(3):337-45. 
33. Patel N, Mohammadi A, Rhatigan R. A comparative analysis 
of mast cell quantification in five common dermatoses: lichen 
simplex chronicus, psoriasis, lichen planus, lupus, and insect 
bite/allergic contact dermatitis/nummular dermatitis. ISRN 
Dermatol. 2012;2012:759630. doi: 10.5402/2012/759630.
34. Kim JW, Ko HC, Kim MB, Kim DW, Kim JM, Kim BS. Fea-
tures of Staphylococcus aureus colonization in patients with 
 nummular eczema. Br J Dermatol. 2013;168(3):658-60. doi: 
10.1111/j.1365-2133.2012.11072.x.
35. Olze H, Zuberbier T. Comorbidities between nose and skin 
allergy. Curr Opin Allergy Clin Immunol. 2011;11:457-63. 
doi: 10.1097/ACI.0b013e32834a9764.
36. Lugović-Mihić L. The increase in Croatia’s scabies incidence: 
how did refugees and traveling contribute? Travel Med Infect 
Dis. 2019;29:74. doi: 10.1016/j.tmaid.2019.02.002. 
37. Aoyama H, Tanaka M, Hara M, Tabata N, Tagami H. Num-
mular eczema: an addition of senile xerosis and unique cutane-
ous reactivities to environmental aeroallergens. Dermatology. 
1999;199(2):135-9. doi:10.1159/000018220.
38. Bakula A, Lugović-Mihić L, Šitum M, Turčin J, Šinković A. 
Contact allergy in the mouth: diversity of clinical presentations 
and diagnosis of common allergens relevant to dental practice. 
Acta Clin Croat. 2011;50(4):553-61.
39. Romić Brtan R, Brtan A, Romić I, Cvitanović H, Duvančić, T 
Lugović-Mihić, L. Quality of life and perception of disease in 
patients with chronic leg ulcer. Acta Clin Croat. 2015: 54 
(3)309-14. 
40. Lugović-Mihić L, Pilipović-Knežević K, Crnarić I, Šitum M, 
Duvančić T. Differential diagnostics of cheilitis. .How to clas-
sify cheilitis? Acta Clin Croat. 2018;57:342-51. doi: 10.20471/
acc.2018.57.02.16.
41. Novak-Bilić G, Vučić M, Japundžić I, Meštrović-Štefekov J, 
Stanić-Duktaj S, Lugović-Mihić L. Irritant and allergic con-
tact dermatitis – skin lesion characteristics. Acta Clin Croat. 
2018;57(4):713-20. doi: 10.20471/acc.2018.57.04.13.
Sažetak 
ČIMBENICI KOJI DOPRINOSE REGRESIJI KRONIČNE URTIKARIJE/ANGIOEDEMA  
I NUMULARNOG DERMATITISA – KOJI LABORATORIJSKI NALAZI SU KLJUČNI?
L. Lugović-Mihić, I. Bukvić, V. Bulat i I. Japundžić 
Tijekom rada s dermatološkim bolesnicima javlja se pitanje koje dijagnostičke testove i postupke koristiti u obradi bole-
snika, osobito kod slučajeva kronične urtikarije (KU) i numularnog ekcematoidog dermatitisa, bolesti kod kojih liječenje 
pratećih bolesti i infekcija može biti značajno za ishod liječenja bolesnika. U ovoj retrospektivnoj studiji istražili smo utjecaj 
pratećih bolesti na ishod bolesti kože, na temelju medicinske dokumentacije bolesnika s KU i ekcematoidnim dermatitisom 
koje smo usporedili s kontrolnom skupinom. Uključili smo bolesnike zaprimljene u našu dermatološku kliniku tijekom 6 
godina te smo analizirali njihove laboratorijske nalaze, povezane čimbenike i ishode bolesti kože koji su zabilježeni nakon 2 
godine praćenja i liječenja. U usporedbi s kontrolnim skupinama bolesnici s KU imali su značajno učestalije pozitivne nalaze 
na Helicobacter (H.) pylori (p=0,020), češće potvrđene alergije (p=0,006), češće povišen IgE (p=0,011) i češće patološke nala-
ze štitnjače (p=0,049), dok su bolesnici s ekcematoidnim dermatitisom imali značajno učestalije pozitivne nalaze H. pylori 
(p=0,046). Značajna regresija obiju dermatoza bolesti zabilježena je nakon provedenog liječenja pratećih, uz utvrđenu zna-
čajnu korist provedenog liječenja infekcije bakterijom H. pylori. To ukazuje na važnost dijagnostike pratećih infekcija (osobi-
to H. pylori i urogenitalnih infekcija), potvrđenih alergija, endokrinih poremećaja (osobito štitnjače kod bolesnika s KU) i 
vrijednosti serumskih tumorskih biljega, kao i njihovog liječenja, što utječe na ishod ovih bolesti kože. 
Ključne riječi: Kronična urtikarija; Dijagnostičke tehnike i postupci; Ekcem; Helicobacter pylori; Kožne bolesti; Hrvatska
